Chapter 10 : Filamentous Fungi

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Filamentous Fungi, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815455/9781555813970_Chap10-1.gif /docserver/preview/fulltext/10.1128/9781555815455/9781555813970_Chap10-2.gif


This chapter discusses the most common causes of invasive mold infections, and provides a brief mention of particular molds that are less frequent causes of infection. The hyaline septate molds are covered first, with emphasis on species, species, and . A section talks about two dimorphic fungal pathogens, and , and also about less commonly encountered hyaline septate molds. Next, it discusses the , and and species are included because they are the genera most frequently encountered. Clinical Laboratory Standards Institute (CLSI) document 38-A addresses the standard broth dilution methods for determining antifungal resistance in the filamentous fungi . Alternatively, some authors have shown the utility of other methods, such as the Etest, for determining antifungal resistance in the filamentous fungi. The presence of a single colony of a mold in a respiratory specimen may simply represent the presence of transient fungal flora or a plate contaminant; however, it could also be evidence of an invasive fungal infection in an immunocompromised host. Every mycology laboratory should be able to definitively identify certain filamentous fungi. Microscopic examination reveals the spore morphology, the conidiophore, and the method of conidiogenesis. These features, when studied with identification keys and atlases, should afford the identification of the most commonly encountered filamentous fungi.

Citation: Procop G, Hayden R, Roberts G. 2009. Filamentous Fungi, p 195-219. In Hayden R, Carroll K, Tang Y, Wolk D (ed), Diagnostic Microbiology of the Immunocompromised Host. ASM Press, Washington, DC. doi: 10.1128/9781555815455.ch10
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


1. Abramowsky, C. R.,, D. Quinn,, W. D. Bradford, and, N. F. Conant. 1974. Systemic infection by fusarium in a burned child. The emergence of a saprophytic strain. J. Pediatr. 84: 561564.
2. Adam, O.,, A. Auperin,, F. Wilquin,, J.- H. Bourhis,, B. Gachot, and, E. Chachaty. 2004. Treatment with piperacillin-tazobactam and false-Positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clin. Infect. Dis. 38: 917920.
3. Adam, R. D.,, M. L. Paquin,, E. A. Petersen,, M. A. Saubolle,, M. G. Rinaldi,, J. G. Corcoran,, J. N. Galgiani, and, R. E. Sobonya. 1986. Phaeohyphomycosis caused by the fungal genera Bipolaris and Exserohilum. A report of 9 cases and review of the literature. Medicine (Baltimore) 65: 203217.
4. Aguado, J. M.,, R. Valle,, R. Arjona,, J. C. Ferreres, and, J. A. Gutierrez. 1992. Aortic bypass graft infection due to Aspergillus: report of a case and review. Clin. Infect. Dis. 14: 916921.
5. Aguilar C.,, I. Pujol,, J. Sala, and, J. Guarro. 1998. Antifungal susceptibilities of Paecilomyces species. Antimicrob. Agents Chemother. 42: 16011604.
6. Alvarez-Lerma, F.,, J. Nolla-Salas,, C. Leon,, M. Palomar,, R. Jorda,, N. Carrasco,, F. Bobillo, and, E. S. Group. 2003. Candiduria in critically ill patients admitted to intensive care medical units. Intensive Care Med. 29: 10691076.
7. Anaissie, E.,, H. Kantarijian,, J. Ro,, R. Hopfer,, K. Rolston,, V. Fainstein, and, G. Bodey. 1988. The emerging role of Fusarium infection in patients with cancer. Medicine 67: 7783.
8. Anaissie, E. J.,, R. Hachem,, C. Legrand,, P. Legenne,, P. Nelson, and, G. P. Bodey. 1992. Lack of activity of amphotericin B in systemic murine fusarial infection. J. Infect. Dis. 165: 11551157.
9. Anaissie E. J.,, P. Nelson,, M. Beremand,, D. Kontoyiannis, and, M. Rinaldi. 1992. Fusarium-caused hyalohyphomycosis: an overview. Curr. Top. Med. Mycol. 4: 231249.
10. Anaissie, E. J.,, and M. G. Rinaldi. 1990. Fusarium and the immunocompromised host: liaisons dangeureuses. New York State J. Med. 90: 586587.
11. Arend, S. M.,, R. G. Westendorp,, F. P. Kroon,, J. W. van’t Wout,, J. P. Vandenbroucke,, A. van Es, et al. 1996. Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipients. Clin. Infect. Dis. 22: 920925.
12. Ayliffe, G. A. 1991. Role of the environment of the operating suite in surgical wound infection. Rev. Infect. Dis. 13 (Suppl. 10): S800S804.
13. Baddley, J. W.,, T. P. Stroud,, D. Salzman, and, P. G. Pappas. 2001. Invasive mold infections in allogeneic bone marrow transplant recipients. Clin. Infect. Dis. 32: 13191324.
14. Becker, W. K.,, W. G. Cioffi, Jr.,, A. T. McManus,, S. H. Kim,, W. F. McManus,, A. D. Mason, and, B. A. Pruitt, Jr. 1991. Fungal burn wound infection. A 10-year experience. Arch. Surg. 126: 4448.
15. Berenguer, J.,, J. Diaz-Mediavilla,, D. Urra, and, P. Munoz. 1990. Central nervous system infection caused by Pseudallescheria boydii: case report and review. Rev. Infect. Dis. 60: 531537.
16. Bhat, S. V.,, D. L. Paterson,, M. G. Rinaldi, and, P. J. Veldkamp. 2007. Scedosporium prolificans brain abscess in a patient with chronic granulomatous disease: successful combination therapy with voriconazole and terbinafine. Scand. J. Infect. Dis. 39: 8790.
17. Bisno, A. 1984. Cutaneous infections: microbiologic and epidemiologic considerations. Am. J. Med. 76: 172179.
18. Blackwell, V.,, K. Ahmed,, C. O’Docherty, and, R. J. Hay. 2000. Cutaneous hyalophyphomycosis caused by Paecilomyces lilacinus in a renal transplant patient. Br. J. Dermatol. 143: 873875.
19. Boggild, A. K.,, S. M. Poutanen,, S. Mohan, and, M. A. Ostrowski. 2006. Disseminated phaeohyphomycosis due to Ochroconis gallopavum in the setting of advanced HIV infection. Med. Mycol. 44: 777782.
20. Bolignano, G.,, and G. Criseo. 2003. Disseminated nosocomial fungal infection by Aureobasidium pullulans var. melanigenum: a case report. J. Clin. Microbiol. 41: 44834485.
21. Boutati, E. I.,, and E. J. Anaissie. 1997. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years’ experience at a center and implications for management. Blood 90: 9991008.
22. Brandt, M. E.,, and D. W. Warnock. 2003. Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi. J. Chemother. 15 (Suppl. 2): 3647.
23. Braun, J.,, F. de Keyser,, J. Brandt,, H. Mielants,, J. Sieper, and, E. Veys. 2001. New treatment options in spondyloarthropathies: increasing evidence for significant efficacy of antitumor necrosis factor therapy. Curr. Opin. Rheumatol. 13: 245249.
24. Bretagne, S.,, A. Marmorat-Khuong,, M. Kuentz,, J. P. Latge,, E. Bart-Delabesse, and, C. Cordonnier. 1997. Serum Aspergillus galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients. J. Infect. 35: 715.
25. Briegel, J.,, H. Forst,, B. Spill,, A. Haas,, B. Grabein,, M. Haller, et al. 1995. Risk factors for systemic fungal infections in liver transplant recipients. Eur. J. Clin. Microbiol. Infect. Dis. 14: 375382.
26. Cahill, B. C.,, J. R. Hibbs,, K. Savik,, B. A. Juni, and, B. M. Dosland. 1997. Aspergillus airway colonization and invasive disease after lung transplantation. Chest 112: 11601164.
27. Carey, J.,, R. D’Amico,, D. A. Sutton, and, M. G. Rinaldi. 2003. Paecilomyces lilacinus vaginitis in an immunocompetent patient. Emerg. Infect. Dis. 9: 11551158.
28. Carrillo-Munoz, A. J.,, G. Quindos,, M. Ruesga,, O. del Valle,, J. Peman,, E. Canton,, J. M. Hernandez-Molina, and, P. Santos. 2006. In vitro antifungal susceptibility testing of filamentous fungi with Sensititre Yeast One. Mycoses 49: 293297.
29. Castaldo, P., et al. 1991. Clinical spectrum of fungal infections after orthotopic liver transplantation. Arch. Surg. 126: 149156.
30. Castro, L. G.,, A. Salebian, and, M. N. Sotto. 1990. Hyalohyphomycosis by Paecilomyces lilacinus in a renal transplant patient and a review of human Paecilomyces species infections. J. Med. Vet. Mycol. 28: 1526.
31. Caux, F.,, S. Aractingi,, H. Baurmann,, P. Reygagne,, H. Dombret,, S. Romand, and, L. Dubertret. 1993. Fusarium solani cutaneous infection in a neutropenic patient. Dermatology 186: 232235.
32. Chan-Tack, K. M.,, C. L. Thio,, N. S. Miller,, C. L. Karp,, C. Ho, and, W. G. Merz. 1999. Paecilomyces lilacinus fungemia in adult marrow transplant recipient. Med. Mycol. 37: 5760.
33. Christianson, J. C.,, W. Engber, and, D. Andes. 2003. Primary cutaneous cryptococcosis in immunocompetent and immunocompromised hosts. Med. Mycol. 41: 177188.
34. Chua, J. D.,, S. M. Gordon,, J. Banbury,, G. S. Hall, and, G. W. Procop. 2001. Relapsing Exophiala jeanselmei phaeohyphomycosis in a lung-transplant patient. Transpl. Infect. Dis. 3: 235238.
35. Cisneros, J. M., et al. 1998. Pneumonia after heart transplantation: a multiinstitutional study. Clin. Infect. Dis. 27: 324331.
36. Clancy, C. J.,, R. A. Jaber,, H. L. Leather,, J. R. Wingard,, B. Staley,, L. J. Wheat,, C. L. Cline,, K. H. Rand,, D. Schain,, M. Baz, and, M. H. Nguyen. 2007. Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients. J. Clin. Microbiol. 45: 17591765.
37. Clarke, D. E.,, and T. A. Raffin. 1990. Infectious complications of indwelling long-term central venous catheters. Chest 97: 966972.
38. Cofrancesco, E.,, C. Boschetti,, M. A. Viviani,, C. Bargiggia,, A. M. Tortorano,, M. Cortellaro, and, C. Zanussi. 1992. Efficacy of liposomal amphotericin B (AmBisome) in the eradication of Fusarium infection in a leukaemic patient. Haematologica 77: 280283.
39. Collins, L. A., et al. 1994. Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J. Infect. Dis. 170: 644652.
40. Connolly, P.,, M. Durkin,, A. LeMonte,, J. Witt III,, E. Hackett,, L. Egan, et al. 2007. Rapid diagnosis of systemic and invasive mycoses. Clin. Microbiol. Newsl. 29: 16.
41. Cornet, M.,, H. Mallat,, D. Somme,, E. Guerot,, G. Kac,, J. L. Mainardi,, P. Fornes,, L. Gutmann, and, V. Lavarde. 2003. Fulminant invasive pulmonary aspergillosis in immunocompetent patients—a two-case report. Clin. Microbiol. Infect. 9: 12241227.
42. Couppie, P.,, C. Aznar,, B. Carme, and, M. Nacher. 2006. American histoplasmosis in developing countries with a special focus on patients with HIV: diagnosis, treatment, and prognosis. Curr. Opin. Infect. Dis. 19: 443449.
43. Cummings, J. R.,, G. R. Jamison,, J. W. Boudreaux,, M. J. Howles,, T. J. Walsh, and, R. T. Hayden. 2007. Cross-reactivity of non-Aspergillus fungal species in the Aspergillus galactomannan enzyme immunoassay. Diagn. Microbiol. Infect. Dis. 59: 113115.
44. Das, A.,, M. E.,, L. A. Ross,, H. L. Monforte,, M. V. Horn,, G. L. Lam, and, W. H. Mason. 2000. Paecilomyces variotii in a pediatric patient with lung transplantation. Pediatr. Transplant. 4: 328332.
45. Dean, D. A.,, and K. W. Burchard. 1996. Fungal infection in surgical patients. Am. J. Surg. 171: 374382.
46. Decostere, A.,, K. Hermans,, T. De Baere,, F. Pasmans, and, F. Haesebrouck. 2003. First report on Cryptococcus laurentii associated with feather loss in a glossy starling (Lamprotornis chalybaeus). Avian Pathol. 32: 309311.
47. de la Monte, S. M.,, and G. M. Hutchins. 1985. Disseminated Curvularia infection. Arch. Pathol. Lab. Med. 109: 872874.
48. Dignani, M. C.,, and E. Anaissie. 2004. Human fusariosis. Clin. Microbiol. Infect. 10: 6775.
49. Eggimann, P.,, J. Garbino, and, D. Pittet. 2003. Epidemiology of Candida species infections in critically ill non-immunosup-pressed patients. Lancet Infect. Dis. 3: 685702.
50. Ellis, M. E.,, H. Clink,, D. Younge, and, B. Hainau. 1994. Successful combined surgical and medical treatment of fusarium infection after bone marrow transplantation. Scand. J. Infect. Dis. 26: 225228.
51. Espinel-Ingroff, A. 1998. Comparison of in-vitro activities of new triazole SCH 56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J. Clin. Microbiol. 36: 29502956.
52. Fantry, L. 2000. Gastrointestinal infections in the immunocompromised host. Curr. Opin. Gastroenterol. 16: 45.
53. Fica, A.,, M. C. Diaz,, M. Luppi,, R. Olivares,, L. Saez,, M. Ba-boor, and, P. Vasquez. 2003. Unsuccessful treatment with voriconazole of a brain abscess due to Cladophialophora bantiana. Scand. J. Infect. Dis. 35: 892893.
54. Fincher, R. M.,, J. F. Fisher,, R. D. Lovell,, C. L. Newman,, A. Espinel-Ingroff, and, H. J. Shadomy. 1991. Infection due to the fungus Acremonium ( Cephalosporium). Medicine 70: 398409.
55. Frater, J. L.,, G. S. Hall, and, G. W. Procop. 2001. Histologic features of zygomycosis: emphasis on perineural invasion and fungal morphology. Arch. Pathol. Lab. Med. 125: 375378.
56. Fung-Tomc, J. C.,, E. Huczko,, B. Minassian, and, D. P. Bonner. 1998. In vitro activity of a new oral triazole, BMS-207147 (ER-3-346). Antimicrob. Agents Chemother. 42: 313318.
57. Reference deleted.
58. Gamis, A. S.,, T. Gudnason,, G. S. Giebink, and, N. K. Ramsay. 1991. Disseminated infection with Fusarium in recipients of bone marrow transplants. Rev. Infect. Dis. 13: 10771088.
59. Gan, G. G.,, A. Kamarulzaman,, K. Y. Goh,, K. P. Ng,, S. L. Na, and, T. S. Soo-Hoo. 2002. Non-sporulating Chrysosporium: an opportunistic fungal infection in a neutropenic patient. Med. J. Malaysia 57: 118122.
60. Gangneux, J. P.,, D. Lavarde,, S. Bretagne,, C. Guiguen, and, V. Gandemer. 2002. Transient Aspergillus antigenaemia: think of milk. Lancet 359: 1251.
61. Giacchino, M.,, N. Chiapello,, S. Bezzio,, F. Fagioli,, P. Saracco,, A. Alfarano,, V. Martini,, G. Cimino,, P. Martino, and, C. Girmenia. 2006. Aspergillus galactomannan enzyme-linked immunosorbent assay cross-reactivity caused by invasive Geotrichum capitatum. J. Clin. Microbiol. 44: 34323434.
62. Goldblum, D.,, B. E. Frueh,, S. Zimmerli, and, M. Bohnke. 2000. Treatment of postkeratitis Fusarium endophthalmitis with amphotericin B lipid complex. Cornea 19: 853856.
63. Greig, J.,, M. Harkness,, P. Taylor,, C. Hashmi,, S. Liang, and, J. Kwan. 2003. Peritonitis due to the dermatiaceous mold Exophiala dermatitidis complicating continuous ambulatory peritoneal dialysis. Clin. Microbiol. Infect. 9: 713715.
64. Groll, A. H.,, and T. J. Walsh. 2001. Uncommon opportunistic fungi: new nosocomial threats. Clin. Microbiol. Infect. 7: 824.
65. Groll, A.,, and T. J. Walsh. 1998. Pharmacology of antifungal compounds. Adv. Pharmacol. 44: 343350.
66. Groll, A. H.,, P. M. Shah,, C. Mentzel,, M. Schneider,, G. Just-Nuebling, and, K. Huebner. 1996. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J. Infect. 33: 2332.
67. Reference deleted.
68. Guarro, J.,, and J. Gené. 1995. Opportunistic fusarial infections in humans. Eur. J. Clin. Microbiol. Infect. Dis. 14: 741754.
69. Guarro, J.,, W. Gams,, I. Pujol, and, J. Genéé. 1997. Acremonium species: new emerging fungal opportunists—in vitro antifungal susceptibilities and review. Clin. Infect. Dis. 25: 12221229.
70. Guiot, H. M.,, J. Bertran-Pasarell,, L. M. Tormos,, C. Gonzalez-Keelan,, G. W. Procop,, J. Fradera,, C. Sanchez-Sergenton, and, W. Mendez. 2007. Ileal perforation and reactive hemophagocytic syndrome in a patient with disseminated histoplasmosis: the role of the real-time polymerase chain reaction in the diagnosis and successful treatment with amphotericin B lipid complex. Diagn. Microbiol. Infect. Dis. 57: 429433.
71. Hayden, R. T.,, S. Pounds,, R. Schaufele,, T. Sein, and, T. J. Walsh. Expression of galactomannan antigenemia in pediatric oncology patients with invasive aspergillosis. Pediatr. Infect. Dis. J., in press.
72. Hebrecht, R., et al. 2002. Acremonium strictum pulmonary infecion in a leukemic patient successfully treated with posaconazole after failure of amphotericin B. Eur. J. Clin. Microbiol. Infect. Dis. 21: 814817.
73. Heenequin, C., et al. 1997. Invasive Fusarium infections: a retrospective survey of 31 cases. J. Med. Vet. Mycol. 33: 107114.
74. Reference deleted.
75. Hiemenz, J. W.,, B. Kennedy, and, K. Kwon-Chung. 1990. Invasive fusariosis associated with an injury with a stringray barb. J. Med. Vet. Mycol. 28: 209213.
76. Hiestand, P. C., et al. 1992. The new cyclosporine derivative, SDZ IMM 125: in vitro and in vivo pharmacological effects. Transplant. Proc. 19: 3138.
77. Hilmarsdottir, I.,, S. B. Thorsteinsson,, P. Asmundsson,, M. Bodvarsson, and, M. Arnadottir. 2000. Cutaneous infection caused by Paecilomyces lilicanus in a renal transplant patient: treatment with voriconazole. Scand. J. Infect. Dis. 32: 331332.
78. Holzheimer, R. G.,, and H. Dralle. 2002. Management of mycoses in surgical patients—review of the literature. Eur. J. Med. Res. 7: 200226.
79. Hope, W. W.,, T. J. Walsh, and, D. W. Denning. 2005. Laboratory diagnosis of invasive aspergillosis. Lancet Infect. Dis. 5: 609622.
80. Hopkins, M. A.,, and D. M. Treloar. 1997. Mucormycosis in diabetes. Am. J. Crit. Care 6: 363367.
81. Horre, R.,, B. Jovanic,, G. Marklein,, G. Schumacher,, N. Friedrichs,, T. Neuhaus,, G. S. de Hoog,, W. H. Becker,, S. M. Choi, and, K. P. Schaal. 2003. Fatal pulmonary scedosporiosis. Mycoses 46: 418421.
82. Horvath, J.,, S. Dummer,, J. Lloyd,, B. Walker,, W. H. Merrill, and, W. H. Frist. 1993. Infection in the transplanted and native lung after single lung transplantation. Chest 104: 681685.
83. Husain, S., et al. 2003. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin. Infect. Dis. 37: 221229.
84. Husain, S.,, D. L. Paterson,, S. M. Studer,, M. Crespo,, J. Pilewski,, M. Durkin,, J. L. Wheat,, B. Johnson,, L. McLaughlin,, C. Bentsen,, K. R. McCurry, and, N. Singh. 2007. Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients. Transplantation 83: 13301336.
85. Husain, S.,, M. M. Wagener, and, N. Singh. 2001. Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg. Infect. Dis. 7: 17.
86. Jabbour, N.,, J. Reyes,, S. Kusne,, M. Martin, and, J. Fung. 1996. Cryptococcal meningitis after liver transplantation. Transplantation 61: 146167.
87. John, G. T., et al. 1994. Cryptococcosis in renal allograft recipients. Transplantation 58: 855856.
88. Kaliamurthy, J.,, C. M. Kalavathy,, M. D. Ramalingam,, D. A. Prasanth,, C. A. Jesudasan, and, P. A. Thomas. 2004. Keratitis due to a coelomycetous fungus: case reports and review of the literature. Cornea 23: 312.
89. Kanj, S. S., et al. 1996. Fungal infections in lung and heart-lung transplant recipients: report of 9 cases and review of the literature. Medicine 75: 142156.
90. Kantarcioglu, A. S.,, and G. S. de Hoog. 2004. Infections of the central nervous system by melanized fungi: a review of cases presented between 1999 and 2004. Mycoses 47: 413.
91. Kappe, R.,, and A. Schulze-Berge. 1993. New cause for false-positive results with the Pastorex Aspergillus antigen latex agglutination test. J. Clin. Microbiol. 31: 24892490.
92. Kawazu, M.,, Y. Kanda,, Y. Nannya,, K. Aoki,, M. Kurokawa,, S. Chiba,, T. Motokura,, H. Hirai, and, S. Ogawa. 2004. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1→3)-beta- d-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J. Clin. Microbiol. 42: 27332741.
93. Kedzierska, A. 2007. (1→3)-Beta- d-glucan—a new marker for the early serodiagnosis of deep-seated fungal infections in humans. Pol. J. Microbiol. 56: 39.
94. Kershaw, P.,, R. Freeman,, D. Templeton,, P. C. DeGirolami,, U. DeGirolami,, D. Tarsy,, S. Hoffmann,, G. Eliopoulos, and, A. W. Karchmer. 1990. Pseudallescheria boydii infection of the central nervous system. Arch. Neurol. 47: 468472.
95. Klont, R. R.,, M. A. Mennink-Kersten, and, P. E. Verweij. 2004. Utility of Aspergillus antigen detection in specimens other than serum specimens. Clin. Infect. Dis. 39: 14671474.
96. Kontoyiannis, D. P.,, V. C. Wessel,, G. P. Bodey, and, K. V. Rolston. 2000. Zygomycosis in the 1990s in a tertiary care cancer center. Clin. Infect. Dis. 30: 851856.
97. Kouvousis, N.,, G. Lazaros,, E. Christoforatou,, S. Deftereos,, D. Petropoulou-Milona,, M. Lelekis, and, A. Zacharoulis. 2002. Pacemaker pocket infection due to Acremonium species. Pacing Clin. Electrophysiol. 25: 378379.
98. Krcmery, V., Jr., et al. 1997. Fungaemia due to Fusarium spp. in cancer patients. J. Hosp. Infect. 36: 223228.
99. Kusne, S., et al. 1988. Infections after liver transplantation, an analysis of 101 consecutive cases. Medicine 67: 132143.
100. Lamaris, G. A.,, G. Chamilos,, R. E. Lewis,, A. Safdar,, I. I. Raad, and, D. P. Kontoyiannis. 2006. Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989–2006. Clin. Infect. Dis. 43: 15801584.
101. Lass-Florl, C.,, M. Cuenca-Estrella,, D. W. Denning, and, J. L. Rodriguez-Tudela. 2006. Antifungal susceptibility testing in Aspergillus spp. according to EUCAST methodology. Med. Mycol. 44 (Suppl.) : 319325.
102. Lass-Florl, C.,, K. Griff,, A. Mayr,, A. Petzer,, G. Gastl,, H. Bonatti,, M. Freund,, G. Kropshofer,, M. P. Dierich, and, D. Nachbaur. 2005. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br. J. Haematol. 131: 201207.
103. Latenser, B. A. 2003. Fusarium infections in burn patients: a case report and review of the literature. J. Burn Care Rehab. 24: 285288.
104. Lederberg, J.,, R. Shope, and, S. Oaks. 1992. Emerging Infections: Microbial Threats to Health in the United States. National Academy Press, Washington, DC.
105. Lee, F. Y.,, S. B. Mossad, and, K. A. Adal. 1999. Pulmonary mucormycosis: the last 30 years. Arch. Intern. Med. 159: 13011309.
106. Lee, J. H.,, N. R. Slifman,, S. K. Gershon,, E. T. Edwards,, W. D. Schwieterman,, J. N. Siegel,, R. P. Wise,, S. L. Brown,, J. N. Udall, Jr., and, M. M. Braun. 2002. Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept. Arthritis Rheum. 46: 25652570.
107. Lee, J.,, W. W. Yew,, C. S. Chiu,, P. C. Wong,, C. F. Wong, and, E. P. Wang. 2002. Delayed sternotomy wound infection due to Paecilomyces variotii in a lung transplant recipient. J. Heart Lung Transplant. 21: 11311134.
108. Lin, S. J.,, J. Schranz, and, S. M. Teutsch. 2001. Aspergillosis case-fatality rate: systematic review of the literature. Clin. Infect. Dis. 32: 358366.
109. Lionakis, M. S.,, and D. P. Kontoyiannis. 2003. Glucocorticoids and invasive fungal infections. Lancet 362: 18281838.
110. Lipsky, P. E.,, D. M. van der Heijde,, E. W. St. Clair,, D. E. Furst,, F. C. Breedveld,, J. R. Kalden,, J. S. Smolen,, M. Weisman,, P. Emery,, M. Feldmann,, G. R. Harriman,, R. N. Maini, et al. 2000. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N. Engl. J. Med. 343: 15941602.
111. Liu, K., et al. 2002. Morphologic criteria for the preliminary indentification of Fusarium, Paecilomyces, and Acremonium species by histopathology. Am. J. Clin. Pathol. 109: 4554.
112. Lopez, F. A.,, R. S. Crowley,, L. Wastila,, H. A. Valantine, and, J. S. Remington. 1998. Scedosporium apiospermum ( Pseudallescheria boydii) infection in a heart transplant recipient: a case of mistaken identity. J. Heart Lung Transplant. 17: 321324.
113. Madariaga, M. G.,, A. Tenorio, and, L. Proia. 2003. Trichosporon inkin peritonitis treated with caspofungin. J. Clin. Microbiol. 41: 58275829.
114. Maertens, J.,, J. Van Eldere,, J. Verhaegen,, E. Verbeken,, J. Verschakelen, and, M. Boogaerts. 2002. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J. Infect. Dis. 186: 12971306.
115. Mahfouz, T.,, and E. Anaissie. 2003. Prevention of fungal infections in the immunocompromised host. Curr. Opin. Investig. Drugs 4: 974990.
116. Marchetti, O.,, J. Bille,, U. Fluckiger,, P. Eggimann,, C. Ruef,, J. Garbino,, T. Calandra,, M. P. Glauser,, M. G. Tauber,, D. Pittet, et al. 2004. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991–2000. Clin. Infect. Dis. 38: 311320.
117. Reference deleted.
118. Marr, K. A.,, R. A. Carter,, F. Crippa,, A. Wald, and, L. Corey. 2002. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 34: 909917.
119. Marr, K. A.,, M. Laverdiere,, A. Gugel, and, W. Leisenring. 2005. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin. Infect. Dis. 40: 17621769.
120. Marr, K. A.,, T. Patterson, and, D. Denning. 2002. Aspergillosis: pathogenesis, clinical manifestations, and therapy. Infect. Dis. Clin. N. Am. 16: 875894.
121. Martagon-Villamil, J.,, N. Shrestha,, M. Sholtis,, C. M. Isada,, G. S. Hall,, T. Bryne,, B. A. Lodge,, L. B. Reller, and, G. W. Procop. 2003. Identification of Histoplasma capsulatum from culture extracts by real-time PCR. J. Clin. Microbiol. 41: 12951298.
122. Martino, P.,, R. Gastaldi,, R. Raccah, and, C. Girmenia. 1994. Clinical patterns of Fusarium infections in immunocompromised patients. J. Infect. 1: 715.
123. Martino, P., et al. 1990. Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemic patients. Rev. Infect. Dis. 12: 570582.
124. Marty, F. M.,, D. H. Barouch,, E. P. Coakley, and, L. R. Baden. 2003. Disseminated trichosporonosis caused by Trichosporon loubieri. J. Clin. Microbiol. 41: 53175320.
125. Mattei, D.,, D. Rapezzi,, N. Mordini,, F. Cuda,, N. C. Lo,, M. Musso,, A. Arnelli,, S. Cagnassi, and, A. Gallamini. 2004. False-positive Aspergillus galactomannan enzyme-linked immunosorbent assay results in vivo during amoxicillinclavulanic acid treatment. J. Clin. Microbiol. 42: 53625363.
126. McGinnis, M. R.,, and L. Pasarell. 1998. In vitro evaluation of terbinafine and itraconazole against dematiaceous fungi. Med. Mycol. 36: 243246.
127. McGinnis, M. R.,, and L. Pasarell. 1998. In vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with consideration of phylogenetic implications. J. Clin. Microbiol. 36: 23532355.
128. Mennink-Kersten, M. A.,, J. P. Donnelly, and, P. E. Verweij. 2004. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect. Dis. 4: 349357.
129. Mennink-Kersten, M. A.,, A. Warris, and, P. E. Verweij. 2006. 1,3-Beta- d-glucan in patients receiving intravenous amoxicillin-clavulanic acid. N. Engl. J. Med. 354: 28342835.
130. Mennink-Kersten, M. A.,, D. Ruegebrink,, R. R. Klont,, A. Warris,, F. Gavini,, H. J. Op den Camp, and, P. E. Verweij. 2005. Bifidobacterial lipoglycan as a new cause for false-positive Platelia Aspergillus enzyme-linked immunosorbent assay reactivity. J. Clin. Microbiol. 43: 39253931.
131. Mennink-Kersten, M.,, and P. E. Verweij. 2007. Non-culture-based diagnostics for opportunistic fungi. Infect. Dis. Clin. N. Am. 20: 711727.
132. Merz, W. G.,, J. E. Karp,, M. Hoagland,, M. Jett-Goheen,, J. M. Junkins, and, A. F. Hood. 1988. Diagnosis and successful treatment of fusariosis in the compromised host. J. Infect. Dis. 158: 10461055.
133. Miro, O.,, J. Ferrando,, V. Lecha, and, J. M. Campistol. 1994. Subcutaneous abscesses caused by Acremonium falciforme in a kidney transplant recipient. Med. Clin. (Barcelona) 102: 316.
134. Mohammedi, I.,, M. A. Piens,, C. Audigier-Valette,, J. C. Gantier,, L. Argaud,, O. Martin, and, D. Robert. 2004. Fatal Microascus trigonosporus (anamorph Scopulariopsis) pneumonia in a bone marrow transplant recipient. Eur. J. Clin. Microbiol. Infect. Dis. 23: 215217.
135. Moore, C. B.,, N. Sayers,, J. Mosquera,, J. Slaven, and, D. W. Denning. 2000. Antifungal drug resistance in Aspergillus. J. Infect. 41: 203220.
136. Mootsikapun, P.,, and S. Srikulbutr. 2006. Histoplasmosis and penicilliosis: comparison of clinical features, laboratory findings and outcome. Int. J. Infect. Dis. 10: 6671.
137. Morse, S. 1996. Factors in the emergence of infectious diseases. Emerg. Infect. Dis. 7: 715.
138. Mousa, H. A. 1999. Fungal infection of burn wounds in patients with open and occlusive treatment methods. East Mediterr. Health J. 5: 333336.
139. Murayama, N.,, R. Takimoto,, M. Kawai,, M. Hiruma,, K. Takamori, and, K. Nishimura. 2003. A case of subcutaneous phaeohyphomycotic cyst due to Exophiala jeanselmei complicated with systemic lupus erythematosus. Mycoses 46: 145148.
140. Musa, M. O.,, A. Al Eisa,, M. Halim,, E. Sahovic,, M. Gyger,, N. Chaudhri,, F. Al Mohareb,, P. Seth,, M. Aslam, and, M. Aljurf. 2000. The sprectrum of Fusarium infection in immunocompromised patients with hematological malignancies and in non-immunocompromised patients. Br. J. Hematol. 108: 544548.
141. Musher, B.,, D. Fredricks,, W. Leisenring,, S. A. Balajee,, C. Smith, and, K. A. Marr. 2004. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J. Clin. Microbiol. 42: 55175522.
142. Myers, A.,, J. Clark, and, H. Foster. 2002. Tuberculosis and treatment with infliximab. N. Engl. J. Med. 346: 623626.
143. Naidu, J.,, and S. M. Singh. 1992. Hyalohyphomycosis caused by Paecilomyces variotii: a case report, animal pathogenicity and in vitro sensitivity. Antonie Van Leeuwenhoek 62: 225230.
144. Nakelchik, M.,, and J. E. Mangino. 2002. Reactivation of histoplasmosis after treatment with infliximab. Am. J. Med. 112: 78.
145. Negroni, R.,, S. H. Helou,, N. Petri,, A. M. Robles,, A. Arechavala, and, M. H. Bianchi. 2004. Case study. Posaconazole treatment of disseminated phaeohyphomycosis due to Exophiala spinifera. Clin. Infect. Dis. 38: e15e20.
146. Nir-Paz, R.,, H. Elinav,, G. E. Pierard,, D. Walker,, A. Maly,, M. Shapiro,, R. C. Barton, and, I. Polacheck. 2003. Deep infection by Trichophyton rubrum in an immunocompromised patient. J. Clin. Microbiol. 41: 52984301.
147. Nobrega, J. P.,, S. Rosemberg,, A. M. Adami,, E. M. Heins-Vaccari,, S. Lacaz Cda, and, T. de Brito. 2003. Fonsecaea pedrosoi cerebral phaeohyphomycosis (“chromoblastomycosis”): first human culture-proven case reported in Brazil. Rev. Inst. Med. Trop. Sao Paulo 45: 217220.
148. Nosari, A., et al. 2000. Mucormycosis in hematologic malignancies: an emerging fungal infection. Haematologica 85: 10681071.
149. Nucci, M.,, and and E. Anaissie. 2002. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implication for diagnosis and management. Clin. Infect. Dis. 35: 909920.
150. Nunley, D. R.,, O. N.,, W. F. Grgurich,, A. T. Iacono,, P. A. Williams,, R. J. Keenan, et al. 1998. Pulmonary aspergillosis in cystic fibrosis lung transplant recipients. Chest 114: 13211329.
151. Obayashi, T., et al. 1995. Plasma (1→3)-beta- d-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 345: 1720.
152. Ochiai, T. A., et al. 1987. Effect of a new immunosuppressive agent, FK506 on heterotropic cardiac allotransplantation in the rat. Transplant. Proc. 19: 12841286.
153. Odabasi, Z.,, G. Mattiuzzi,, E. Estey,, H. Kantarjian,, F. Saeki,, R. J. Ridge,, P. A. Ketchum,, M. A. Finkelman,, J. H. Rex, and, L. Ostrosky-Zeichner. 2004. Beta- d-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin. Infect. Dis. 39: 199205.
154. Ohira, S.,, K. Isoda,, H. Hamanaka,, K. Takahashi,, K. Nishimoto, and, H. Mizutani. 2002. Case report. Phaeohyphomycosis caused by Phialophora verrucosa developed in a patient with non-HIV acquired immunodeficiency syndrome. Mycoses 45: 5054.
155. Orth, B.,, R. Frei,, P. H. Itin,, M. G. Rinaldi,, B. Speck,, A. Gratwohl, and, A. F. Widmer. 1996. Outbreak of invasive mycosis caused by Paecilomyces lilacinus from a contaminated skin lotion. Ann. Intern. Med. 125: 799806.
156. Ostrosky-Zeichner, L.,, B. D. Alexander,, D. H. Kett,, J. Vazquez,, P. G. Pappas,, F. Saeki,, P. A. Ketchum,, J. Wingard,, R. Schiff,, H. Tamura,, M. A. Finkelman, and, J. H. Rex. 2005. Multicenter clinical evaluation of the (1→3) beta- d-glucan assay as an aid to diagnosis of fungal infections in humans. Clin. Infect. Dis. 41: 654659.
157. Panackal, A. A.,, and K. A. Marr. 2004. Scedosporium/Pseudallescheria infections. Semin. Respir. Crit. Care Med. 25: 171181.
158. Paradowski, L. 1997. Saprophytic fungal infections and lung transplantation—revisited. J. Heart Lung Transplant. 16: 524531.
159. Parfrey, N. 1986. Improved diagnosis and prognosis of mucormycosis. A clinicopathologic study of 33 cases. Medicine 65: 113123.
160. Pasqualotto, A. C.,, and D. W. Denning. 2006. Postoperative aspergillosis. Clin. Microbiol. Infect. 12: 10601076.
161. Patterson, T. F.,, V. T. Andriole,, M. J. Zervos,, D. Therasse, and, C. A. Kauffman. 1990. The epidemiology of pseudallescheriasis complicating transplantation: nosocomial and community acquired infection. Mycoses 33: 297302.
162. Perfect, J. R.,, and W. A. Schell. 1996. The new fungal opportunists are coming. Clin. Infect. Dis. 22: S112S118.
163. Pettit, T. H.,, R. J. Olson,, R. Y. Foos, and, W. J. Martin. 1980. Fungal endophthalmitis following intraocular lens implantation. A surgical epidemic. Arch. Ophthalmol. 98: 10251039.
164. Pfaller, M. A.,, and D. J. Diekema. 2004. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J. Clin. Microbiol. 42: 44194431.
165. Pfaller, M. A., et al. Reference Method for Broth Dilution Antifungal Susceptibility Testing. CLSI Document 38-A22. CLSI, Wayne, PA.
166. Pfaller, M. A.,, F. Marco,, S. A. Messer, and, R. N. Jones. 1998. In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi. Diagn. Microbiol. Infect. Dis. 30: 251255.
167. Pfeiffer, C. D.,, J. P. Fine, and, N. Safdar. 2006. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin. Infect. Dis. 42: 14171427.
168. Pickering, J.,, H. Sant,, C. Bowles,, W. Roberts, and, G. Woods. 2005. Evaluation of a (1→3)-beta- d-glucan assay for diagnosis of invasive fungal infections. J. Clin. Microbiol. 43: 59575962.
169. Pisetsky, D. S. 2000. Tumor necrosis factor blockers in rheumatoid arthritis. N. Engl. J. Med. 342: 810811.
170. Pitisuttithum, P.,, R. Negroni,, J. R. Graybill,, B. Bustamante,, P. Pappas,, S. Chapman,, R. S. Hare, and, C. J. Hardalo. 2005. Activity of posaconazole in the treatment of central nervous system fungal infections. J. Antimicrob. Chemother. 56: 745755.
171. Prabhu, R. M.,, and R. Patel. 2004. Mucormycosis and entomophthoramycosis: a review of the clnical manifestations, diagnosis and treatment. Clin. Microbiol. Infect. 10: 3147.
172. Procop, G. W. 2006. Evaluation of molecular diagnostic assays for fungal infections. J. Mol. Diagn. 8: 297298.
173. Pruitt, B. A., Jr.,, A. T. McManus,, S. H. Kim, and, C. W. Goodwin. 1998. Burn wound infections: current status. World J. Surg. 22: 135145.
174. Queiroz-Telles, F.,, M. R. McGinnis,, I. Salkin, and, J. R. Graybill. 2003. Subcutaneous mycoses. Infect. Dis. Clin. N. Am. 17: 5985.
175. Rajendran, C.,, B. K. Khaitan,, R. Mittal,, M. Ramam,, M. Bhardwaj, and, K. K. Datta. 2003. Phaeohyphomycosis caused by Exophiala spinifera in India. Med. Mycol. 41: 437441.
176. Rangel-Guerra, R. A.,, H. R. Martinez,, C. Saenz,, F. Bosques-Padilla, and, I. Estrada-Bellmann. 1996. Rhinocerebral and systemic mucormycosis. Clinical experience with 36 cases. J. Neurol. Sci. 143: 1930.
177. Reis, A.,, R. Sundmacher,, K. Tintelnot,, H. Agostini,, H. E. Jensen, and, C. Althaus. 2000. Successful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazole. Br. J. Ophthalmol. 84: 932933.
178. Reuben, A.,, E. Anaissie,, P. E. Nelson,, R. Hashem,, C. Legrand,, D. H. Ho, and, G. P. Bodey. 1989. Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution method. Antimi-crob. Agents Chemother. 33: 16471649.
179. Revankar, S. G.,, D. A. Sutton, and, M. G. Rinaldi. 2004. Primary central nervous system phaeohyphomycosis: a review of 101 cases. Clin. Infect. Dis. 38: 206216.
180. Rodgers, G. L.,, J. Mortensen,, M. C. Fisher,, A. Lo,, A. Cress-well, and, S. S. Long. 2000. Predictors of infectious complications after burn injuries in children. Pediatr. Infect. Dis. J. 19: 990995.
181. Roilides, E. S., et al. 1995. Acremonium fungemia in two immunocompromised children. Pediatr. Infect. Dis. J. 14: 548550.
182. Romani, L. 2004. Immunity to fungal infections. Nat. Rev. Immunol. 4: 123.
183. Rotstein, C.,, L. Brock, and, R. S. Roberts. 1995. The incidence of first Hickman catheter-related infection and predictors of catheter removal in cancer patients. Infect. Control Hosp. Epidemiol. 16: 451458.
184. Sampathkumar, P.,, and C. V. Paya. 2001. Fusarium infection after solid-organ transplantation. Clin. Infect. Dis. 32: 12371240.
185. Sandborn, W. J.,, and S. B. Hanauer. 1999. Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. Inflamm. Bowel Dis. 5: 119133.
186. Sanguinetti, M.,, B. Posteraro,, L. Pagano,, G. Pagliari,, L. Fianchi,, L. Mele,, M. La Sorda,, A. Franco, and, G. Fadda. 2003. Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis. J. Clin. Microbiol. 41: 39223925.
187. Schelenz, S.,, and W. R. Gransden. 2003. Candidaemia in a London teaching hospital: analysis of 128 cases over a 7-year period. Mycoses 46: 390396.
188. Schell, W. A.,, and J. R. Perfect. 1996. Fatal disseminated Acremonium strictum infection in a neutropenic host. J. Clin. Microbiol. 34: 13331336.
189. Schwartz, J. 1982. The diagnosis of deep mycosis by morphological methods. Hum. Pathol. 13: 519533.
190. Sellier, P.,, J. J. Monsuez,, C. Lacroix,, C. Feray,, J. Evans,, C. Minozzi,, F. Vayre,, P. Del Giudice,, M. Feuilhade,, C. Pinel,, D. Vittecoq, and, J. Passeron. 2000. Recurrent subcutaneous infection due to Scopulariopsis brevicaulis in a liver transplant recipient. Clin. Infect. Dis. 30: 820823.
191. Sharkey, P. K., et al. 1990. Itraconazole treatment of phaeohyphomycosis. J. Am. Acad. Dermatol. 23: 577586.
192. Shenoy, R.,, U. A. Shenoy, and, Z. H. al Mahrooqui. 2003. Keratomycosis due to Trichophyton mentagrophytes. Mycoses 46: 157158.
193. Shing, M. M.,, M. Ip,, C. K. Li,, K. W. Chik, and, P. M. Yuen. 1996. Paecilomyces variotii fungemia in a bone marrow transplant patient. Bone Marrow Transplant. 17: 281283.
194. Siemann, M.,, M. Koch-Dorfler, and, M. Gaude. 1998. False-positive results in premature infants with the Platelia Aspergillus sandwich enzyme-linked immunosorbent assay. Mycoses 41: 373377.
195. Singh, N. 2000. Antifungal prophylaxis in organ transplant recipients: seeking clarity amidst controversy. Clin. Infect. Dis. 31: 545553.
196. Singh, N. 2002. The changing face of invasive aspergillosis in liver transplant recipients. Liver Transplant. 8: 10711072.
197. Singh, N. 2003. Fungal infections in the recipients of solid organ transplantation. Infect. Dis. Clin. N. Am. 17: 113134.
198. Singh, N., et al. 1997. Invasive aspergillosis in liver transplant recipients in the 1990s. Transplantation 64: 716720.
199. Singh, N.,, F. Y. Chang,, T. Gayowski, and, I. R. Marino. 1997. Infections due to dematiaceous fungi in organ transplant recipients. Clin. Infect. Dis. 24: 369374.
200. Singh, N.,, T. Gayowski,, M. M. Wagener,, H. Doyle, and, I. R. Marino. 1997. Invasive fungal infections in liver transplant recipients receiving tacrolimus as primary immunosuppressive agent. Clin. Infect. Dis. 24: 179184.
201. Singh, N.,, and S. Husain. 2003. Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management. J. Heart Lung Transplant. 22: 258266.
202. Sirisanthana, T.,, and K. Supparatpinyo. 1998. Epidemiology and management of penicilliosis in human immunodeficiency virus-infected patients. Int. J. Infect. Dis. 3: 4853.
203. Steinbach, W. J.,, and J. R. Perfect. 2003. Scedosporium species infections and treatments. J. Chemother. 15 (Suppl. 2) : 1627.
204. St.-Germain, G., et al. 1996. Fusarium, p. 122–123. In G. St.-Germain et al. (ed.), Identifying Filamentous Fungi. Blackwell Science, Blemont, CA.
205. Strabelli, T. M., et al. 1990. Acremonium infection after heart transplant. Rev. Soc. Bras. Med. Trop. 23: 233.
206. Stynen, D.,, A. Goris,, J. Sarfati, and, J. P. Latge. 1995. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J. Clin. Microbiol. 33: 497500.
207. Stynen, D.,, J. Sarfati,, A. Goris,, M. C. Prevost,, M. Lesourd,, H. Kamphuis,, V. Darras, and, J. P. Latge. 1992. Rat monoclonal antibodies against Aspergillus galactomannan. Infect. Immun. 60: 22372245.
208. Sulahian, A.,, F. Boutboul,, P. Ribaud,, T. Leblanc,, C. Lacroix, and, F. Derouin. 2001. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer 91: 311318.
209. Supparatpinyo, K.,, C. Khamwan,, V. Baosoung,, K. E. Nelson, and, T. Sirisanthana. 1994. Disseminated Penicillium marneffei infection in Southeast Asia. Lancet 344: 110113.
210. Supparatpinyo, K.,, K. E. Nelson,, W. G. Merz,, B. J. Breslin,, C. R. Cooper, Jr.,, C. Kamwan, and, T. Sirisanthana. 1993. Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens. Antimicrob. Agents Chemother. 37: 24072411.
211. Supparatpinyo, K.,, J. Perriens,, K. E. Nelson, and, T. Sirisanthana. 1998. A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus. N. Engl. J. Med. 339: 17391743.
212. Swoboda-Kopec, E.,, M. M. Wroblewska,, A. Rokosz, and, M. Luczak. 2003. Mixed bloodstream infection with Staphylococcus aureus and Penicillium chrysogenum in an immunocompromised patient: case report and review of the literature. Clin. Microbiol. Infect. 9: 11161117.
213. Tadros, T. S.,, K. A. Workowski,, R. J. Siegel,, S. Hunter, and, D. A. Schwartz. 1998. Pathology of hyalohyphomycosis caused by Scedosporium apiospermum ( Pseudallescheria boydii): an emerging mycosis. Hum. Pathol. 29: 12661272.
214. Tan, T. Q.,, A. K. Ogden,, J. Tillman,, G. J. Demmler, and, M. G. Rinaldi. 1992. Paecilomyces lilacinus catheter-related fungemia in immunocompromised pediatric patient. J. Clin. Microbiol. 30: 24792483.
215. Tang, Y. W.,, L. Haijing,, M. M. Durkin,, S. E. Sefers,, S. Meng,, P. A. Connolly,, C. W. Sutton, and, L. J. Wheat. 2006. Urine polymerase chain reaction is not as sensitive as urine antigen for the diagnosis of disseminated histoplasmosis. Diagn. Microbiol. Infect. Dis. 4: 283287.
216. Teixeira, A. B.,, P. Trabasso,, M. L. Moretti-Branchini,, F. H. Aoki,, A. C. Vigorito,, M. Miyaji,, Y. Mikami,, M. Takada, and, A. Z. Schreiber. 2003. Phaeohyphomycosis caused by Chaetomium globosum in an allogeneic bone marrow transplant recipient. Mycopathologia 156: 309312.
217. Tollemar, J.,, B. G. Ericzon,, L. Barkholt,, J. Andersson,, O. Ringden, and, C. G. Groth. 1990. Risk factors for deep Candida infections in liver transplant recipients. Transplant. Proc. 22: 18261827.
218. Reference deleted.
219. Torre-Cisnero, J.,, O. L. Lopez,, S. Kusne,, A. J. Martinez, and, T. E. Starzl. 1993. CNS aspergillosis in organ transplantation: a clinicopathologic study. J. Neurol. Neurosurg. Psych. 56: 188193.
220. Travis, L. B.,, G. D. Roberts, and, W. R. Wilson. 1985. Clinical significance of Pseudallescheria boydii: a review of 10 years’ experience. Mayo Clinic Proc. 60: 531537.
221. Trifilio, S. M.,, C. L. Bennett,, P. R. Yarnold,, J. M. McKoy,, J. Parada,, J. Mehta,, G. Chamilos,, F. Palella,, L. Kennedy,, K. Mullane,, M. S. Tallman,, A. Evens,, M. H. Scheetz,, W. Blum, and, D. P. Kontoyiannis. 2007. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant. 39: 425429.
222. Tritz, D.,, and G. L. Woods. 1993. Fatal disseminated infection with Aspergillus terreus in the immunocompromised patient. Clin. Infect. Dis. 16: 118122.
223. Ustun, C.,, G. Huls,, M. Stewart, and, K. A. Marr. 2006. Resistant Microascus cirrosus pneumonia can be treated with a combination of surgery, multiple anti-fungal agents and a growth factor. Mycopathologia 162: 299302.
224. van Burik, J. A.,, R. Colven, and, D. H. Spach. 1998. Cutaneous aspergillosis. J. Clin. Microbiol. 36: 31153121.
225. Vartivarian, S. E.,, E. J. Anaissie, and, G. P. Bodey. 1993. Emerging fungal pathogens in immunocompromised patients: classification, diagnosis, and management. Clin. Infect. Dis. 17 (Suppl. 2) : S487S491.
226. Verdaguer, V.,, T. J. Walsh,, W. Hope, and, K. J. Cortez. 2007. Galactomannan antigen detection in the diagnosis of invasive aspergillosis. Expert Rev. Mol. Diagn. 7: 2132.
227. Verweij, P. E.,, C. M. Weemaes,, J. H. Curfs,, S. Bretagne, and, J. F. Meis. 2000. Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis. J. Clin. Microbiol. 38: 39003901.
228. Verweij, P. E.,, J. P. Latge,, A. J. Rijs,, W. J. Melchers,, B. E. de Pauw,, J. A. Hoogkamp-Korstanje, and, J. F. Meis. 1995. Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies. J. Clin. Microbiol. 33: 31503153.
229. Verweij, P. E.,, K. Brinkman,, H. P. Kremer,, B. J. Kullberg, and, J. F. Meis. 1999. Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management. J. Clin. Microbiol. 37: 11861189.
230. Viscoli, C.,, M. Machetti,, P. Gazzola,, A. De Maria,, D. Paola,, M. T. Van Lint,, F. Gualandi,, M. Truini, and, A. Bacigalupo. 2002. Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis. J. Clin. Microbiol. 40: 14961499.
231. Viviani, M. A.,, E. Cofrancesco,, C. Boschetti,, A. M. Tortorano, and, M. Cortellaro. 1991. Eradication of Fusarium infection in a leukopenic patient treated with liposomal amphotericin B. Mycoses 34: 255256.
232. Waite, R. T.,, and G. L. Woods. 1998. Evaluation of BACTEC MYCO/F lytic medium for recovery of mycobacteria and fungi from blood. J. Clin. Microbiol. 36: 11761179.
233. Wald, A., et al. 1997. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J. Infect. Dis. 175: 14591466.
234. Walsh, T. J.,, R. W. Finberg,, C. Arndt,, J. Hiemenz,, C. Schwartz,, D. Bodensteiner,, P. Pappas,, N. Seibel,, R. N. Greenberg,, S. Dummer,, M. Schuster, and, J. S. Holcenberg. 1999. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. N. Engl. J. Med. 340: 764771.
235. Walsh, T. J.,, A. Groll,, J. Hiemenz,, R. Fleming,, E. Roilides, and, E. Anaissie. 2004. Infections due to emerging and uncommon medically important fungal pathogens. Clin. Microbiol. Infect. 10: 4866.
236. Walsh, T. J.,, J. L. Goodman,, P. Pappas,, I. Bekersky,, D. N. Buell,, M. Roden,, J. Barrett, and, E. J. Anaissie. 2001. Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: a maximum tolerated dose study. Antimicrob. Agents Chemother. 45: 34873496.
237. Walsh, T. J.,, J. W. Hiemenz,, N. L. Seibel,, J. R. Perfect,, G. Horwith,, L. Lee,, J. L. Silber,, M. J. DiNubile,, A. Reboli,, E. Bow,, J. Lister, and, E. J. Anaissie. 1998. Amphotericin B lipid complex in patients with invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin. Infect. Dis. 26: 13831396.
238. Wang, T. K.,, W. Chiu,, S. Chim,, T. M. Chan,, S. S. Wong, and, P. L. Ho. 2003. Disseminated Ochroconis gallopavum infection in a renal transplant recipient: the first reported case and a review of the literature. Clin. Nephrol. 60: 415423.
239. Warris, A.,, A. Bjorneklett, and, P. Gaustad. 2001. Invasive pulmonary aspergillosis associated with infliximab therapy. N. Engl. J. Med. 344: 10991100.
240. Wheat, J. 2005. Galactomannan antigenemia detection for diagnosis of invasive aspergillosis. Clin. Microbiol. Newsl. 27: 51.
241. Wheat, J.,, E. Hackett,, M. Durkin,, P. Connolly,, R. Petraitiene,, T. Walsh,, K. Knox, and, C. Hage. 2007. Histoplasmosis-associated cross-reactivity in the BioRad Platelia Aspergillus enzyme immunoassay. Clin. Vaccine Immunol. 14: 638640.
242. Wheat, L. J.,, and C. A. Kauffman. 2003. Histoplasmosis. Infect. Dis. Clin. N. Am. 17: 119.
243. Wheeler, M. S.,, M. R. McGinnis,, W. A. Schell, and, D. H. Walker. 1981. Fusarium infection in burned patients. Am. J. Clin. Pathol. 75: 304311.
244. White, P. L.,, R. Barton,, M. Guiver,, C. J. Linton,, S. Wilson,, M. Smith,, B. L. Gomez,, M. J. Carr,, P. T. Kimmitt,, S. Seaton,, K. Rajakumar,, T. Holyoake,, C. C. Kibbler,, E. Johnson,, R. P. Hobson,, B. Jones, and, R. A. Barnes. 2006. A consensus on fungal polymerase chain reaction diagnosis?: a United Kingdom-Ireland evaluation of polymerase chain reaction methods for detection of systemic fungal infections. J. Mol. Diagn. 8: 376384.
245. Wildfeurer, A.,, H. P. Seidl,, I. Paule, and, A. Haberreiter. 1997. In vitro activity of voriconazole against yeasts, moulds, and dermatophytes in comparison with fluconazole, amphotericin B and griseofulvin. Arzneimittelforschung 47: 12571263.
246. Williamson, P. R.,, K. J. Kwon-Chung, and, J. I. Gallin. 1992. Successful treatment of Paecilomyces variotii in a patient with chronic granulomatous disease and a review of Paecilomyces species infections. Clin. Infect. Dis. 14: 10231026.
247. Willinger, B.,, G. Kopetzky,, F. Harm,, P. Apfalter,, A. Makristathis,, A. Berer,, A. Bankier, and, S. Winkler. 2004. Disseminated infection with Nattrassia mangiferae in an immunosuppressed patient. J. Clin. Microbiol. 42: 478480.
248. Wolff, M. A.,, and R. Ramphal. 1995. Use of amphotericin B lipid complex for treatment of disseminated cutaneous Fusarium infection in a neutropenic patient. Clin. Infect. Dis. 20: 15681569.
249. Wood, K. L.,, C. A. Hage,, K. S. Knox,, M. B. Kleiman,, A. Sannuti,, R. B. Day,, L. J. Wheat, and, H. L. Twigg III. 2003. Histoplasmosis after treatment with anti-tumor necrosis factor-alpha therapy. Am. J. Respir. Crit. Care Med. 167: 12791282.
250. Woods, G.,, M. H. Miceli,, M. L. Grazziutti,, W. Zhao,, B. Barlogie, and, E. Anaissie. 2007. Serum Aspergillus galactomannan antigen values strongly correlate with outcome of invasive aspergillosis: a study of 56 patients with hematologic cancer. Cancer 110: 830834.
251. Yehia, M.,, M. Thomas,, H. Pilmore,, W. Van Der Merwe, and, I. Dittmer. 2004. Subcutaneous black fungus (phaeohyphomycosis) infection in renal transplant recipients: three cases. Transplantation 77: 140142.
252. Yoo, J. H.,, S. M. Choi,, D. G. Lee,, J. H. Choi,, W. S. Shin,, W. S. Min, and, C. C. Kim. 2005. Prognostic factors influencing infection-related mortality in patients with acute leukemia in Korea. J. Korean Med. Sci. 20: 3135.
253. Zhang, Z.,, H. Correa, and, R. E. Begue. 2002. Tuberculosis and treatment with infliximab. N. Engl. J. Med. 346: 623626.


Generic image for table
Table 1.

Filamentous fungi that medical mycology laboratories should be able to identify

Citation: Procop G, Hayden R, Roberts G. 2009. Filamentous Fungi, p 195-219. In Hayden R, Carroll K, Tang Y, Wolk D (ed), Diagnostic Microbiology of the Immunocompromised Host. ASM Press, Washington, DC. doi: 10.1128/9781555815455.ch10
Generic image for table
Table 2.

Strengths and limitations of selected antifungal agents

Citation: Procop G, Hayden R, Roberts G. 2009. Filamentous Fungi, p 195-219. In Hayden R, Carroll K, Tang Y, Wolk D (ed), Diagnostic Microbiology of the Immunocompromised Host. ASM Press, Washington, DC. doi: 10.1128/9781555815455.ch10

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error